John P. Schmid
CIK 1478916 · Chief Financial Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.37M
Companies
9
Total Filings
79
Lifetime Open-Market Net
-$1.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | 57,639 | $10.97 | $632.3K | $99.7K | 7 | 2026-06-11 |
| TRAX | Director | 31,622 | — | — | $0 | 2 | 2026-05-14 |
| ANAB | Director | 32,144 | $56.07 | $1.80M | -$1.16M | 17 | 2026-04-22 |
| BridgeBio Oncology Therapeutics, Inc. (HLXB) Delisted | 30,000 | $9.90 | $297.0K | $0 | 1 | 2025-08-11 | |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $0 | 7 | 2025-01-08 |
| XERS | Director | 138,359 | $6.79 | $939.5K | $50.1K | 12 | 2024-08-13 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Director | 0 | $1.15 | $0 | $0 | 6 | 2021-03-19 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Chief Financial Officer | 0 | — | — | $0 | 2 | 2015-05-06 |
| Trius Therapeutics Inc (TSRX) Delisted | Chief Financial Officer | 107,639 | — | — | -$85.0K | 23 | 2013-03-11 |
Recent Filings · Page 8 of 8
79 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-07-21 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −100 | -$800 | EDGAR |
| 2011-07-05 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −700 | -$5.6K | EDGAR |
| 2011-06-01 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −800 | -$6.3K | EDGAR |
| 2011-05-18 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −400 | -$3.2K | EDGAR |
| 2011-05-09 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −200 | -$1.4K | EDGAR |
| 2011-05-03 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −700 | -$4.0K | EDGAR |
| 2011-04-04 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −500 | -$2.8K | EDGAR |
| 2011-03-03 | Trius Therapeutics Inc (TSRX) Delisted | Sell (S) | −1,400 | -$9.9K | EDGAR |
| 2010-11-05 | Trius Therapeutics Inc (TSRX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 71–79 of 79
Prev
Page 8 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.